appeals_desk

TL3 Regular · Columbus, OH, US

I have written a lot of prior-authorisation appeals, mostly successfully. The templates on this site are mine and they are deliberately unemotional.

Joined 25 December 2024 · last posted 10h · groups: wiki-editors

144 posts, newest first. Showing up to 150.

Revisiting: Mobile reading experience on long topics Replied, post #16 · Meta › Site feedback · 27 Jul 2026 · 13 likes This settles it for me, at least until somebody posts a reason it should not.
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #97 · Practice › Interactions · 27 Jul 2026 · 28 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #99 · Start Here › Welcome · 24 Jul 2026 · 8 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #104 · Evidence › Journal club · 23 Jul 2026 · 12 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
Here for the analytics and not much else Replied, post #74 · Lounge › Introductions · 22 Jul 2026 · 12 likes Quietly grateful for the plain phrasing. Not every thread gets that.
What I would want from a home test that does not exist yet Replied, post #45 · Analytics › Home & field testing · 22 Jul 2026 · 8 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
Insurance and replacement policies, compared Replied, post #102 · Sourcing › Logistics · 19 Jul 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
What a certificate commits its issuer to Replied, post #57 · Analytics › COA interpretation · 19 Jul 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Ultrasound and skinfolds: operator dependence in practice Replied, post #64 · Outcomes › Body composition · 18 Jul 2026 · 3 likes Narrowing post #63, because the general version has more than one answer. Speaking only to ultrasound and skinfolds as I have actually seen it, rather than as it is…
Aggregate verification data across the directory, with caveats Replied, post #53 · Sourcing › Independent verification · 17 Jul 2026 · 10 likes I had written a reply contradicting post #51 and deleted it. Here is what survived. Repeat determination on the same product line months apart is the measurement that…
Publication patterns in the BPC-157 literature, examined Replied, post #37 · Compounds › Repair & healing peptides · 16 Jul 2026 · 19 likes I read post #35 twice before replying, because I had assumed the opposite. Nothing in this subcategory is medical advice and several members here are describing…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #70 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 27 likes The arithmetic in post #69 is right; the assumption feeding it is the part to check. Self-reported intake is optimistic by a consistent margin in the published…
Here for the analytics and not much else Replied, post #41 · Lounge › Introductions · 16 Jul 2026 · 5 likes Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already.
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #50 · Pharmacology › Pharmacokinetics · 14 Jul 2026 · 4 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
What a reversed-phase purity number actually is Replied, post #43 · Analytics › HPLC & UHPLC · 11 Jul 2026 · 7 likes Reversed-phase purity number was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Alcohol: what is documented and what is folklore Replied, post #103 · Practice › Interactions · 10 Jul 2026 · 14 likes I read post #101 twice before replying, because I had assumed the opposite. Small methodological point on alcohol: repeating a measurement is cheap and resolves most of…
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #20 · Practice › Side effects · 10 Jul 2026 · 0 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #78 · Sourcing › Independent verification · 9 Jul 2026 · 4 likes Picking up post #77: that is the part I would want checked first. A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #18 · Practice › Dosing & titration · 8 Jul 2026 · 4 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. The reason four-week escalation interval is hard to answer is that the obvious…
What a reversed-phase purity number actually is Replied, post #36 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 23 likes Reversed-phase purity number is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Publication patterns in the BPC-157 literature, examined Replied, post #28 · Compounds › Repair & healing peptides · 5 Jul 2026 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. If you are new and reading this thread for the answer to publication patterns: the…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #50 · Access › Insurance & coverage · 2 Jul 2026 · 24 likes Adding the measurement that post #49 says would settle it. A methods point on Prior authorisation rather than a substantive one: if the comparison is not like for like,…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #68 · Outcomes › Progress reports · 1 Jul 2026 · 3 likes Progress reports that describe an ordinary trajectory are more useful than remarkable ones and are far rarer, because only the remarkable ones feel worth posting. That…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #57 · Analytics › Home & field testing · 25 Jun 2026 · 0 likes Worth separating two things that post #55 runs together. Second-hand on Lateral-flow and colorimetric approaches, so weight it accordingly — someone whose method I…
Request: a per-category review queue Replied, post #54 · Meta › Feature requests · 23 Jun 2026 · 28 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site.
Micro-titration: a disputed topic, argued properly — one year on Replied, post #53 · Practice › Dosing & titration · 22 Jun 2026 · 19 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #41 · Practice › Administration · 13 Jun 2026 · 10 likes Narrowing post #39, because the general version has more than one answer. Drawing up with one needle and injecting with another: a reasonable practice if you have extra…
Racemisation and why it is invisible to a mass measurement Replied, post #28 · Analytics › Impurities & related substances · 10 Jun 2026 · 3 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
Second pass at: A pooled estimate that changed when one trial was added Replied, post #24 · Evidence › Meta-analyses · 7 Jun 2026 · 9 likes That reframing is the whole thing. The facts I already had.
Why fasting instructions for oral semaglutide are not optional advice Replied, post #21 · Compounds › Oral incretins · 30 May 2026 · 16 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #5 · Practice › Storage & stability · 29 May 2026 · 0 likes Two claims get bundled together under Mean kinetic temperature and they need separating. The descriptive one — this is what was observed — is usually well supported.…
Private prescribing in the UK: what is actually involved Replied, post #25 · Regional › UK & Ireland · 28 May 2026 · 0 likes Building on post #24 rather than restating it. Adding a null result on private prescribing. I looked, carefully, and found nothing, and null results deserve posting…
A parcel stationary at a customs facility for nine days Replied, post #64 · Sourcing › Logistics · 28 May 2026 · 0 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. Posting my parcel stationary numbers with the method attached so they can be…
Tracking a shortage from primary sources rather than rumour Replied, post #20 · Access › Shortages · 24 May 2026 · 10 likes Post #18 describes the usual case. This is about the unusual one. A shortage of one presentation is not a shortage of all of them, and the published notices are…
Chain of custody for a sample you posted yourself — one year on Replied, post #20 · Sourcing › Independent verification · 23 May 2026 · 31 likes A supplier that supplies a supplementary certificate for a lot released a year ago has demonstrated that its records exist and are retrievable. That is a real property.…
Personal import allowances, compared — a second dataset Replied, post #126 · Access › International · 19 May 2026 · 1 like On post #122 — agreed on the reasoning, with one qualification. Country-by-country legality: compound approval and legal status differ substantially by jurisdiction.…
Tracking intake honestly when appetite is absent Replied, post #26 · Nutrition & Training › Protein & intake · 15 May 2026 · 15 likes Worth separating two things that post #22 runs together. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass…
A site rotation scheme that is easy enough to actually follow Replied, post #56 · Practice › Administration · 5 May 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
A 10 mg vial reconstituted three different ways, compared Replied, post #18 · Practice › Reconstitution · 5 May 2026 · 5 likes Sensible. I would want the same detail before I acted on it either.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #60 · Data & Tools › Datasets · 4 May 2026 · 0 likes Picking up post #57: that is the part I would want checked first. Where a dataset is used to support a claim in a maintained document, the version used should be cited.…
Request: show the solution author in the topic list — what changed since Replied, post #62 · Meta › Feature requests · 3 May 2026 · 0 likes Picking up post #59: that is the part I would want checked first. Counter-request, gently: please do not add anything on hover. It does not exist on a phone and half…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #29 · Practice › Reconstitution · 28 Apr 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
The anatomy of a question that gets answered within an hour Replied, post #24 · Start Here › How to Ask · 21 Apr 2026 · 3 likes Narrowing post #22, because the general version has more than one answer. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #14 · Practice › Reconstitution · 17 Apr 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Type 2 diabetes and the largest part of the evidence base Replied, post #71 · Clinical › Comorbidities · 17 Apr 2026 · 33 likes Answering the type 2 diabetes question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Sample handling between despatch and injection Replied, post #40 · Analytics › Method validation · 14 Apr 2026 · 4 likes Post #38 describes the usual case. This is about the unusual one. Sample stability during analysis is part of validation and is routinely ignored. A preparation that…
Spike-and-recover accuracy for a peptide assay Replied, post #81 · Analytics › Method validation · 9 Apr 2026 · 20 likes I would keep spike-and-recover accuracy and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
Follow-up: State-level differences that actually matter Replied, post #19 · Regional › North America · 4 Apr 2026 · 3 likes Taking post #16 at face value and following it one step further. The reason State-level differences is hard to answer is that the obvious measurement and the relevant…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #30 · Compounds › Semaglutide · 4 Apr 2026 · 4 likes Building on post #28 rather than restating it. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #17 · Practice › Dosing & titration · 25 Mar 2026 · 25 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #113 · Pharmacology › Pharmacokinetics · 23 Mar 2026 · 21 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
Area percent versus weight percent: the confusion that causes most arguments Started this topic · Analytics › HPLC & UHPLC · 21 Mar 2026 · 1 like Posting this under the heading it deserves: Area percent versus weight percent: the confusion that causes most arguments Everything below is what sits behind that.…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #69 · Sourcing › Regulatory · 18 Mar 2026 · 0 likes I had written a reply contradicting post #65 and deleted it. Here is what survived. A regulator's public assessment report is usually the single best free source on a…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 15 Mar 2026 · 2 likes Worth separating two things that post #65 runs together. Nausea profile of amylin analogues is worth one more sentence than it usually gets, and the sentence is the one…
Why the timeline is on the right and not the left — what changed since Replied, post #6 · Meta › Site feedback · 13 Mar 2026 · 0 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Practical answer on timeline, since the theoretical one is upthread: do the simplest…
The most common factual error about semaglutide on the internet — what changed since Replied, post #39 · Compounds › Semaglutide · 2 Mar 2026 · 21 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #11 · Compounds › Semaglutide · 27 Feb 2026 · 6 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Measurement error in a self-reported exposure Replied, post #57 · Evidence › Study critique · 24 Feb 2026 · 6 likes Where I part company with post #53, and it is a narrow parting. Since measurement error keeps coming up, it should probably be a maintained page rather than a recurring…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #20 · Evidence › Journal club · 24 Feb 2026 · 14 likes Narrowing post #19, because the general version has more than one answer. People arriving without having read it should be welcome and should say so, because a question…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #62 · Analytics › Impurities & related substances · 18 Feb 2026 · 0 likes Two claims get bundled together under rising related-substance and they need separating. The descriptive one — this is what was observed — is usually well supported.…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #31 · Clinical › Special populations · 22 Jan 2026 · 0 likes Building on post #30 rather than restating it. A methods point on Pregnancy and pregnancy planning rather than a substantive one: if the comparison is not like for…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #31 · Evidence › Trials · 3 Jan 2026 · 11 likes Worth separating two things that post #28 runs together. Adding what did not work for me on non-inferiority margins, since the failures never get written up and they…
Filter needles: when they help and what they cost you Replied, post #13 · Devices › Syringes & needles · 28 Dec 2025 · 5 likes Reading back through the filter needles threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
Substitution between formats during a shortage Replied, post #124 · Access › Shortages · 26 Dec 2025 · 5 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. Old habit: I write…
Pooling trials with different estimands — what changed since Replied, post #65 · Evidence › Meta-analyses · 13 Dec 2025 · 16 likes Same experience here, different supplier, so it is at least not unique to one of them.
Documentation that materially improves an appeal's chances Replied, post #82 · Access › Insurance & coverage · 29 Nov 2025 · 3 likes Adding the measurement that post #81 says would settle it. An honest declaration on documentation: I have a prior here and it is strong enough that you should weight…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #38 · Sourcing › Vendor reports · 23 Nov 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Cross-border purchase rules within the EU Replied, post #40 · Regional › European Union · 17 Nov 2025 · 0 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. I have three months of notes on cross-border purchase rules within and the honest…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #55 · Compounds › Tirzepatide · 13 Nov 2025 · 10 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #14 · Practice › Side effects · 31 Oct 2025 · 27 likes The thing about Constipation management that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Where to report an adverse event officially, by region — a second dataset Replied, post #53 · Safety › Adverse events · 25 Oct 2025 · 26 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
Sleep tracking data and its considerable limitations Replied, post #47 · Wellbeing › Sleep · 21 Oct 2025 · 8 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
Payment mechanics and the recovery options that do not exist Replied, post #25 · Sourcing › Payments · 19 Oct 2025 · 0 likes Where I part company with post #21, and it is a narrow parting. I have three months of notes on payment mechanics and the honest summary is that the trend is real and…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #6 · Pharmacology › Pharmacokinetics · 19 Oct 2025 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
Payment mechanics and the recovery options that do not exist Replied, post #18 · Sourcing › Payments · 19 Oct 2025 · 2 likes Coming back to post #16, because the follow-up matters more than the original answer. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #64 · Practice › Dosing & titration · 17 Oct 2025 · 0 likes The version of lowest dose that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
Sleep tracking data and its considerable limitations Replied, post #8 · marked as the solution · Wellbeing › Sleep · 15 Oct 2025 · 7 likes Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise and the trend is more usable than the nightly numbers. Posting it…
What a 2 ppm match establishes, and what it does not Replied, post #56 · Analytics › Mass spectrometry · 2 Oct 2025 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Temperature loggers worth the money — the long version Replied, post #46 · Devices › Cold chain · 25 Sep 2025 · 31 likes On post #44 — agreed on the reasoning, with one qualification. If you are not going to be there, arranging a secure delivery point is worth more than any packing…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #50 · Compounds › Other compounds · 21 Sep 2025 · 8 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Cost per delivered dose, which is the number that matters Replied, post #8 · Access › Pricing · 16 Sep 2025 · 16 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.
How to read a forest plot, properly, from scratch Replied, post #24 · Evidence › Trials · 6 Sep 2025 · 5 likes The arithmetic in post #23 is right; the assumption feeding it is the part to check. Absolute and relative effects answer different questions. Write down the event rate…
Revisiting: German, French and Dutch differences, compared Replied, post #67 · Regional › European Union · 3 Sep 2025 · 0 likes Picking up post #65: that is the part I would want checked first. The most useful reply I ever got about German was a request to state my units. It sounds like pedantry…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #121 · Compounds › Secretagogues & GH axis · 1 Sep 2025 · 0 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #108 · Evidence › Journal club · 25 Aug 2025 · 23 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #93 · Data & Tools › Calculators · 24 Aug 2025 · 6 likes Post #92 answers the question as asked. The question underneath it is different. An honest declaration on titration planner refuses: I have a prior here and it is…
High-resolution MS on aggregates and what it can see Replied, post #51 · Analytics › Mass spectrometry · 24 Aug 2025 · 9 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #28 · Analytics › COA interpretation · 31 Jul 2025 · 29 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Travel coolers and how long they really hold Replied, post #3 · Devices › Cold chain · 30 Jul 2025 · 0 likes Lyophilised material is far more tolerant of a warm transit than a solution would be, which is why suppliers ship dry and why an excursion is not automatically a loss.…
Canadian access and provincial variation — one year on Replied, post #39 · Regional › North America · 28 Jul 2025 · 18 likes This follows post #37 rather than contradicting it. Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the…
Specification in the result column: why that is a meaningful error Replied, post #23 · Analytics › COA interpretation · 26 Jul 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Publishing an inconvenient result: a case study Replied, post #50 · Sourcing › Independent verification · 16 Jul 2025 · 27 likes Agreed, and I will stop repeating the version of this I had been repeating.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #157 · Practice › Reconstitution · 7 Jul 2025 · 1 like Narrowing post #154, because the general version has more than one answer. Swirling until fully clear before drawing is worth the extra minute. A partially dissolved…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #33 · Sourcing › Regulatory · 3 Jul 2025 · 17 likes Adding the measurement that post #30 says would settle it. Regulatory approval is a decision about a specific product from a specific manufacturer. It does not travel…
A report I filed that turned out to be wrong, and the correction Replied, post #130 · Sourcing › Vendor reports · 30 Jun 2025 · 5 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #9 · Practice › Reconstitution · 30 Jun 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Reading a supplier's product description as a marketing document Replied, post #38 · Compounds › Other compounds · 27 Jun 2025 · 19 likes Post #37 is right about the mechanism and I think understates the practical bit. For any compound without a widely available reference standard, retention-time…
Insulin combinations and hypoglycaemia risk Replied, post #22 · Practice › Interactions · 27 Jun 2025 · 25 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
Interim analyses and stopping rules — does this still hold? Replied, post #6 · Evidence › Trials · 24 Jun 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #52 · Clinical › Comorbidities · 30 May 2025 · 7 likes Post #50 describes the usual case. This is about the unusual one. Registry and observational data covering excluded populations is accumulating and is weaker evidence…
Coming back to: An 18-month record including the parts that went badly Replied, post #57 · Outcomes › Progress reports · 26 May 2025 · 20 likes On 18-month record, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
[2026 update] Clearance pathways and what renal impairment changes Replied, post #8 · Pharmacology › Pharmacokinetics · 20 May 2025 · 23 likes Renal impairment changes clearance for some compounds in this class and not others, and the published data is compound-specific rather than class-wide.
Journal club: the CagriSema phase 2 combination paper — a second dataset Started this topic · Evidence › Journal club · 8 May 2025 · 0 likes Journal club: the CagriSema phase 2 combination paper — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #108 · Compounds › Cagrilintide & amylin analogues · 2 May 2025 · 27 likes Post #105 describes the usual case. This is about the unusual one. The interest in combining it with semaglutide is that two different satiety mechanisms might add.…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #44 · Practice › Reconstitution · 28 Apr 2025 · 25 likes That is clearer than the version I had in my head. Thank you.
Reading a trial's population section before its results — does this still hold? Replied, post #46 · Evidence › Trials · 27 Apr 2025 · 0 likes Post #43 is right about the mechanism and I think understates the practical bit. Absolute and relative effects answer different questions. Write down the event rate in…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #17 · Evidence › Trials · 25 Apr 2025 · 0 likes Sample size calculations is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
Coming back to: What published stability data actually covers, and what it does not Replied, post #25 · Practice › Storage & stability · 20 Apr 2025 · 31 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
Asking about a compound your prescriber has not heard of Replied, post #14 · Clinical › Prescriber conversations · 10 Apr 2025 · 14 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I would be interested in a counterexample if anyone…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #14 · Sourcing › Independent verification · 5 Apr 2025 · 8 likes Practical experience of splitting a vial, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #36 · Practice › Interactions · 4 Apr 2025 · 12 likes Building on post #33 rather than restating it. The arithmetic on delayed gastric emptying and oral is the easy part and it is where the errors are, which is an…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #4 · Evidence › Trials · 31 Mar 2025 · 0 likes A note on how Comparators chosen for regulatory reasons gets discussed rather than on Comparators chosen for regulatory reasons itself: the confident posts get the…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #48 · Evidence › Journal club · 16 Mar 2025 · 17 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Certificates issued by the seller versus by a laboratory Replied, post #8 · Analytics › COA interpretation · 16 Mar 2025 · 5 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Consistent declarations and why they matter more than clever ones Replied, post #138 · Sourcing › Logistics · 6 Mar 2025 · 18 likes The arithmetic in post #137 is right; the assumption feeding it is the part to check. Split shipments reduce single-point risk and increase the number of transits.…
An orphaned page with no inbound links Replied, post #14 · Meta › Wiki maintenance · 4 Mar 2025 · 12 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #37 · Practice › Reconstitution · 25 Feb 2025 · 1 like Taking post #36 at face value and following it one step further. My understanding of reconstituting a multi-strength kit is a few years old and may have been…
A promotion I argued against, and why I lost Replied, post #111 · Documentation › Doc review · 25 Feb 2025 · 0 likes Check the links. Promotion frequently breaks a cross-reference because the source topic now points at the document rather than the reverse.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #28 · Devices › Syringes & needles · 8 Feb 2025 · 2 likes Practical answer on Gauge and length selection, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
Pancreatitis history and the risk calculus — a second dataset Replied, post #19 · Safety › Contraindications · 7 Jan 2025 · 17 likes This follows post #18 rather than contradicting it. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #105 · Access › Insurance & coverage · 5 Jan 2025 · 12 likes Adding the boring version of Step therapy requirements, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #11 · Compounds › Semaglutide · 29 Dec 2024 · 12 likes Summarising the published dose-response for semaglutide thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
Coming back to: When to suspect the method rather than the sample Replied, post #11 · Analytics › Method validation · 30 Nov 2024 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #157 · Compounds › Repair & healing peptides · 26 Nov 2024 · 0 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #148 · Compounds › Repair & healing peptides · 25 Nov 2024 · 8 likes The arithmetic in post #147 is right; the assumption feeding it is the part to check. On reading a preclinical wound-healing model, the part that usually goes wrong is…
A promotion I argued against, and why I lost Replied, post #10 · Documentation › Doc review · 21 Nov 2024 · 3 likes Practical experience of promotion, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #128 · Compounds › Other compounds · 19 Nov 2024 · 0 likes Confirming post #127 from a second method, which matters more than confirming it from a second person. Solubility varies far more across this subcategory than within…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #33 · Meta › Wiki maintenance · 11 Nov 2024 · 10 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. Happy to be corrected if someone holds better data than mine.
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #8 · Compounds › Tirzepatide · 8 Nov 2024 · 5 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
Second pass at: Albumin binding and how it produces a long half-life Replied, post #6 · Pharmacology › Pharmacokinetics · 7 Nov 2024 · 18 likes That is consistent with mine, for whatever one more account is worth.
Reading a supplementary appendix and finding the interesting part Replied, post #18 · Evidence › Trials · 5 Nov 2024 · 11 likes I read post #14 twice before replying, because I had assumed the opposite. On reading a supplementary appendix, the part that usually goes wrong is that the question is…
Anxiety in the first weeks: drug, situation, or both Replied, post #13 · Wellbeing › Mental health · 1 Nov 2024 · 0 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Adding the boring version of anxiety, because the interesting version keeps getting…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #12 · Clinical › Special populations · 31 Oct 2024 · 31 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done. It is the kind of thing that…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #43 · Wellbeing › Mental health · 21 Oct 2024 · 33 likes Answering the question post #41 raises rather than the one it answers. The social side of this — how other people respond to visible change — comes up constantly and…
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #3 · Pharmacology › Formulation chemistry · 18 Oct 2024 · 1 like The opening post put the caveat in the right place and I want to underline it. Emulsification and suspensions: some formulations are emulsions or suspensions rather…
Signs of dehydration worth acting on Replied, post #27 · Safety › Adverse events · 9 Oct 2024 · 0 likes If someone has run signs of dehydration worth acting properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone…
Progressive overload when the scale is falling — one year on Replied, post #125 · Nutrition & Training › Resistance training · 5 Oct 2024 · 8 likes Building on post #122 rather than restating it. Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #51 · Practice › Administration · 24 Sep 2024 · 21 likes Site rotation scheme has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
Gallbladder disease risk with rapid weight loss Replied, post #6 · Clinical › Comorbidities · 3 Sep 2024 · 19 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #47 · Clinical › Prescriber conversations · 30 Aug 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. That has been true for the…
Correlation in a self-tracked dataset: what it can support Replied, post #124 · Research Methods › Statistics · 25 Aug 2024 · 6 likes That reframing is the whole thing. The facts I already had.
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #2 · Compounds › Semaglutide · 22 Aug 2024 · 1 like The opening post describes the usual case. This is about the unusual one. What I would want before treating Semaglutide half-life as settled: the method, the sample,…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 26 Jul 2024 · 4 likes Picking up post #10: that is the part I would want checked first. The thing about Sodium that took me longest to accept is that a plausible mechanism is not evidence of…
Journal club: FLOW and the renal composite, component by component Replied, post #58 · Evidence › Journal club · 14 Jul 2024 · 0 likes Taking post #55 at face value and following it one step further. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…